The Government of India is still in talks with American vaccine makers – Moderna and Pfizer – for supply of their Covid-19 jabs. India has managed to administer a total of 38.14 crore doses of three out of the four Covid vaccines approved for emergency use in the country.
Apart from Covishield, Covaxin and Russia’s Sputnik V, Moderna’s mRNA Covid-19 vaccine has also received emergency use authorization (EUA) from the Drugs Controller General of India (DCGI).
Sources in the government say the indemnity clause has emerged as a point of contention in the talks with Moderna and Pfizer.
“We are discussing, but at this moment, we are focusing on the language of the contract for the indemnity clause. Discussion is happening clause by clause with the vaccine manufacturers,” sources told India Today.
US vaccine makers Moderna and Pfizer have been insisting on an indemnity clause before committing to supplying their Covid-19 vaccines to India.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…